Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

STB5 is a negative regulator of azole resistance in Candida glabrata.

Antimicrobial agents and chemotherapy - 1 Feb 2013

Noble Jason A, Tsai Huei-Fung, Suffis Sara D, Su Qin, Myers Timothy G, Bennett John E

Abstract excerpt

The opportunistic yeast pathogen Candida glabrata is recognized for its ability to acquire resistance during prolonged treatment with azole antifungals (J. E. Bennett, K. Izumikawa, and K. A. Marr. Antimicrob. Agents Chemother. 48:1773-1777, 2004). Resistance to azoles is largely mediated by the transcription factor PDR1, resulting in the upregulation of ATP-binding cassette (ABC) transporter proteins and drug...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal Agents
Share to Azoles
Share to Candida glabrata

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Fungal

Share to Fluconazole

Share to Pyrimidines

Share to Triazoles

Share to Voriconazole

Source

Open in PubMed Open full text

Identifiers

PMID: 23229483
DOI: 10.1128/AAC.01278-12
PMCID: PMC3553707

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

STB5 is a negative regulator of azole resistance in Candida glabrata.PMID 23229483Read ↗

Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiaeSemantic proximity Read ↗

Redefining Pleiotropic Drug Resistance in a Pathogenic Yeast: Pdr1 Functions as a Sensor of Cellular Stresses in <i>Candida glabrata</i>Semantic proximity Read ↗

Redefining pleiotropic drug resistance in a pathogenic yeast: Pdr1 functions as a sensor of cellular stresses in Candida glabrataSemantic proximity Read ↗

Genomewide Expression Profile Analysis of the Candida glabrata Pdr1 RegulonSemantic proximity Read ↗

Pdr1 regulates multidrug resistance in <i>Candida glabrata</i>: gene disruption and genome‐wide expression studiesSemantic proximity Read ↗

Azole Resistance in Candida glabrata : Coordinate Upregulation of Multidrug Transporters and Evidence for a Pdr1-Like Transcription FactorSemantic proximity Read ↗

Function of Candida glabrata ABC transporter gene, PDH1Semantic proximity Read ↗

Comparative genomic and transcriptomic analyses unveil novel features of azole resistance and adaptation to the human host in Candida glabrata.Semantic proximity Read ↗

Candida glabrata PDR1 , a Transcriptional Regulator of a Pleiotropic Drug Resistance Network, Mediates Azole Resistance in Clinical Isolates and Petite MutantsSemantic proximity Read ↗

Candida glabrata maintains two HAP1 ohnologs, HAP1A and HAP1B , for distinct roles in ergosterol gene regulation to mediate sterol homeostasis under azole and hypoxic conditionsSemantic proximity Read ↗

Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence.Semantic proximity Read ↗

Regulation of the CgPdr1 Transcription Factor from the Pathogen Candida glabrataSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.